Articles:
Publications:

6 hours ago

What’s at stake as Beijing beats global peers with first approval of novel therapy

What’s at stake as Beijing beats global peers with first approval of novel therapy

China’s drug regulator has for the first time approved a novel, globally trialled medicine ahead of authorities in the United States, Japan and Europe, marking a “historic breakthrough” as the country doubles down on biopharmaceuticals as one of... Read more.

More from South China Morning Post

Turn on Transparency.
Can the US and its allies break China’s grip on rare earths and AI technology?
Owner: Joseph Tsai is the chairman of Alibaba Group More info
Turn on Transparency.
China Merchants Securities drops South Korea ETF as Seoul stock volatility spills over
Owner: Joseph Tsai is the chairman of Alibaba Group More info
Turn on Transparency.
The cask that followed
Owner: Joseph Tsai is the chairman of Alibaba Group More info
More

Keep exploring Perspectify!

Create a free account and bring
more transparency to your news.

Already have an account? Log in.

Today's Media Watch

Your daily guide to the stories shaping media, journalism, and public trust.

Jul. 21, 2026
20 Countries Move to Ban Social Media for Children as Global Crackdown Grow
Neutral | Owner: Vitaliy Laptenok
Jul. 21, 2026
Russia Launches New Wave of Disinformation Against Residents of Sumy Region on TikTok
Public Broadcaster | Owner: Ukrainian Government
Jul. 21, 2026
Paramount and Warner Bros Mega Merger Paused by Judge
Public Broadcaster | Owner: British Government

Learn About Our Fact-Based Transparency System

Our proprietary bias labels help you understand each outlet’s political orientation, editorial independence, and credibility based on factors like ownership, funding, affiliations, content, and media freedom. Learn more in the Perspectify FAQ.

Learn more